Proapoptotic function of integrin β 3 in human hepatocellular carcinoma cells

Yanhua Wu, Jie Zuo, Guoqing Ji, Hexige Saiyin, Xing Liu, Feiyu Yin, Ning Cao, Yunfei Wen, Jian-Jian Li, Long Yu

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Purpose: This study evaluates the proapoptotic function of integrin β 3 in human hepatocellular carcinoma (HCC). Experimental Design: The expression of integrin β 3 in 67 HCC specimens paired with corresponding neighboring nontumorous tissue was studied by quantitative real-time PCR and Western blot. The proapoptotic function of integrin β 3 in SMMC-7721 human hepatoma cells overexpressing ITGB3 (gene coding integrin β 3) was determined through colony formation, serum starvation, and anoikis assay. Results: Compared with neighboring pathologically normal liver tissue, -60% of the HCC specimens showed a significant down-regulated level of integrin β 3 expression. Transient expression of integrin β 3 in SMMC-7721 resulted in an enhanced level of apoptosis and suppression of colony formation. Cell growth inhibition on serum/ligand deprivation and incidences of anoikis were remarkably increased in SMMC-7721 with stable expression of integrin β 3 in comparison with vector control transfectants. In addition, expression of fibrinogen and vitronectin, two native ligands for integrin α vβ 3 in liver, was inhibited, which was correlated with the decreased integrin β 3 expression. Replenishing these ligands to the starved SMMC-7721 stable transfectants effectively restored the proapoptotic function of integrin β 3. Conclusions: Down-regulation of integrin β 3 and its ligands in liver is related to the aggressive growth of HCC. Thus, reconstitution of integrin in HCC may be a potential therapeutic approach to inhibit aggressive growth of liver cancer.

Original languageEnglish (US)
Pages (from-to)60-69
Number of pages10
JournalClinical Cancer Research
Volume15
Issue number1
DOIs
StatePublished - Jan 1 2009
Externally publishedYes

Fingerprint

Integrins
Hepatocellular Carcinoma
Anoikis
Ligands
Liver
Growth
Vitronectin
Liver Neoplasms
Starvation
Serum
Fibrinogen
Real-Time Polymerase Chain Reaction
Research Design
Down-Regulation
Western Blotting
Apoptosis

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Proapoptotic function of integrin β 3 in human hepatocellular carcinoma cells. / Wu, Yanhua; Zuo, Jie; Ji, Guoqing; Saiyin, Hexige; Liu, Xing; Yin, Feiyu; Cao, Ning; Wen, Yunfei; Li, Jian-Jian; Yu, Long.

In: Clinical Cancer Research, Vol. 15, No. 1, 01.01.2009, p. 60-69.

Research output: Contribution to journalArticle

Wu, Y, Zuo, J, Ji, G, Saiyin, H, Liu, X, Yin, F, Cao, N, Wen, Y, Li, J-J & Yu, L 2009, 'Proapoptotic function of integrin β 3 in human hepatocellular carcinoma cells', Clinical Cancer Research, vol. 15, no. 1, pp. 60-69. https://doi.org/10.1158/1078-0432.CCR-08-1028
Wu, Yanhua ; Zuo, Jie ; Ji, Guoqing ; Saiyin, Hexige ; Liu, Xing ; Yin, Feiyu ; Cao, Ning ; Wen, Yunfei ; Li, Jian-Jian ; Yu, Long. / Proapoptotic function of integrin β 3 in human hepatocellular carcinoma cells. In: Clinical Cancer Research. 2009 ; Vol. 15, No. 1. pp. 60-69.
@article{2cbfe896ac164daea51760b266c48ca4,
title = "Proapoptotic function of integrin β 3 in human hepatocellular carcinoma cells",
abstract = "Purpose: This study evaluates the proapoptotic function of integrin β 3 in human hepatocellular carcinoma (HCC). Experimental Design: The expression of integrin β 3 in 67 HCC specimens paired with corresponding neighboring nontumorous tissue was studied by quantitative real-time PCR and Western blot. The proapoptotic function of integrin β 3 in SMMC-7721 human hepatoma cells overexpressing ITGB3 (gene coding integrin β 3) was determined through colony formation, serum starvation, and anoikis assay. Results: Compared with neighboring pathologically normal liver tissue, -60{\%} of the HCC specimens showed a significant down-regulated level of integrin β 3 expression. Transient expression of integrin β 3 in SMMC-7721 resulted in an enhanced level of apoptosis and suppression of colony formation. Cell growth inhibition on serum/ligand deprivation and incidences of anoikis were remarkably increased in SMMC-7721 with stable expression of integrin β 3 in comparison with vector control transfectants. In addition, expression of fibrinogen and vitronectin, two native ligands for integrin α vβ 3 in liver, was inhibited, which was correlated with the decreased integrin β 3 expression. Replenishing these ligands to the starved SMMC-7721 stable transfectants effectively restored the proapoptotic function of integrin β 3. Conclusions: Down-regulation of integrin β 3 and its ligands in liver is related to the aggressive growth of HCC. Thus, reconstitution of integrin in HCC may be a potential therapeutic approach to inhibit aggressive growth of liver cancer.",
author = "Yanhua Wu and Jie Zuo and Guoqing Ji and Hexige Saiyin and Xing Liu and Feiyu Yin and Ning Cao and Yunfei Wen and Jian-Jian Li and Long Yu",
year = "2009",
month = "1",
day = "1",
doi = "10.1158/1078-0432.CCR-08-1028",
language = "English (US)",
volume = "15",
pages = "60--69",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "1",

}

TY - JOUR

T1 - Proapoptotic function of integrin β 3 in human hepatocellular carcinoma cells

AU - Wu, Yanhua

AU - Zuo, Jie

AU - Ji, Guoqing

AU - Saiyin, Hexige

AU - Liu, Xing

AU - Yin, Feiyu

AU - Cao, Ning

AU - Wen, Yunfei

AU - Li, Jian-Jian

AU - Yu, Long

PY - 2009/1/1

Y1 - 2009/1/1

N2 - Purpose: This study evaluates the proapoptotic function of integrin β 3 in human hepatocellular carcinoma (HCC). Experimental Design: The expression of integrin β 3 in 67 HCC specimens paired with corresponding neighboring nontumorous tissue was studied by quantitative real-time PCR and Western blot. The proapoptotic function of integrin β 3 in SMMC-7721 human hepatoma cells overexpressing ITGB3 (gene coding integrin β 3) was determined through colony formation, serum starvation, and anoikis assay. Results: Compared with neighboring pathologically normal liver tissue, -60% of the HCC specimens showed a significant down-regulated level of integrin β 3 expression. Transient expression of integrin β 3 in SMMC-7721 resulted in an enhanced level of apoptosis and suppression of colony formation. Cell growth inhibition on serum/ligand deprivation and incidences of anoikis were remarkably increased in SMMC-7721 with stable expression of integrin β 3 in comparison with vector control transfectants. In addition, expression of fibrinogen and vitronectin, two native ligands for integrin α vβ 3 in liver, was inhibited, which was correlated with the decreased integrin β 3 expression. Replenishing these ligands to the starved SMMC-7721 stable transfectants effectively restored the proapoptotic function of integrin β 3. Conclusions: Down-regulation of integrin β 3 and its ligands in liver is related to the aggressive growth of HCC. Thus, reconstitution of integrin in HCC may be a potential therapeutic approach to inhibit aggressive growth of liver cancer.

AB - Purpose: This study evaluates the proapoptotic function of integrin β 3 in human hepatocellular carcinoma (HCC). Experimental Design: The expression of integrin β 3 in 67 HCC specimens paired with corresponding neighboring nontumorous tissue was studied by quantitative real-time PCR and Western blot. The proapoptotic function of integrin β 3 in SMMC-7721 human hepatoma cells overexpressing ITGB3 (gene coding integrin β 3) was determined through colony formation, serum starvation, and anoikis assay. Results: Compared with neighboring pathologically normal liver tissue, -60% of the HCC specimens showed a significant down-regulated level of integrin β 3 expression. Transient expression of integrin β 3 in SMMC-7721 resulted in an enhanced level of apoptosis and suppression of colony formation. Cell growth inhibition on serum/ligand deprivation and incidences of anoikis were remarkably increased in SMMC-7721 with stable expression of integrin β 3 in comparison with vector control transfectants. In addition, expression of fibrinogen and vitronectin, two native ligands for integrin α vβ 3 in liver, was inhibited, which was correlated with the decreased integrin β 3 expression. Replenishing these ligands to the starved SMMC-7721 stable transfectants effectively restored the proapoptotic function of integrin β 3. Conclusions: Down-regulation of integrin β 3 and its ligands in liver is related to the aggressive growth of HCC. Thus, reconstitution of integrin in HCC may be a potential therapeutic approach to inhibit aggressive growth of liver cancer.

UR - http://www.scopus.com/inward/record.url?scp=58949101974&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58949101974&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-08-1028

DO - 10.1158/1078-0432.CCR-08-1028

M3 - Article

VL - 15

SP - 60

EP - 69

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 1

ER -